JPWO2023054712A1 - - Google Patents
Info
- Publication number
- JPWO2023054712A1 JPWO2023054712A1 JP2023551926A JP2023551926A JPWO2023054712A1 JP WO2023054712 A1 JPWO2023054712 A1 JP WO2023054712A1 JP 2023551926 A JP2023551926 A JP 2023551926A JP 2023551926 A JP2023551926 A JP 2023551926A JP WO2023054712 A1 JPWO2023054712 A1 JP WO2023054712A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021161353 | 2021-09-30 | ||
| PCT/JP2022/036850 WO2023054712A1 (ja) | 2021-09-30 | 2022-09-30 | ペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023054712A1 true JPWO2023054712A1 (https=) | 2023-04-06 |
| JPWO2023054712A5 JPWO2023054712A5 (https=) | 2025-10-08 |
Family
ID=85780814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551926A Pending JPWO2023054712A1 (https=) | 2021-09-30 | 2022-09-30 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250034212A1 (https=) |
| EP (1) | EP4410816A4 (https=) |
| JP (1) | JPWO2023054712A1 (https=) |
| KR (1) | KR20240082377A (https=) |
| CN (1) | CN118103387A (https=) |
| AU (1) | AU2022355276A1 (https=) |
| CA (1) | CA3234324A1 (https=) |
| IL (1) | IL311773A (https=) |
| TW (1) | TW202334179A (https=) |
| WO (1) | WO2023054712A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025070720A1 (ja) * | 2023-09-29 | 2025-04-03 | ペプチドリーム株式会社 | ペプチド |
| TW202535907A (zh) * | 2023-11-10 | 2025-09-16 | 日商肽夢想股份有限公司 | 胜肽、胜肽複合體、醫藥組成物、細胞培養用組成物、以及用於醫療用、診斷用或是研究用之組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
| US5525491A (en) | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
| WO2001066140A1 (en) | 2000-03-09 | 2001-09-13 | Genzyme Corporation | Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| BR0116024A (pt) | 2000-12-07 | 2005-12-13 | Lilly Co Eli | Proteìna de fusão heteróloga e uso da mesma |
| EP1534737A4 (en) * | 2002-04-29 | 2007-10-31 | Univ Saint Louis | PEPTIDANTAGONISTS OF MEMBERS OF THE TGF BETA FAMILY AND THEIR THERAPEUTIC APPLICATION |
| US8188260B2 (en) | 2005-12-06 | 2012-05-29 | The University Of Tokyo | Versatile acylation catalytic RNAs and uses thereof |
| MY165160A (en) | 2010-09-01 | 2018-02-28 | Genzyme Corp | TREATMENT OF MYOCARDIAL INFARCTION USING TGF-ß ANTAGONISTS |
| HRP20201384T1 (hr) | 2014-01-01 | 2020-11-27 | Medivation Technologies Llc | Spojevi i postupci njihove upotrebe |
| US10882894B2 (en) * | 2015-08-11 | 2021-01-05 | Anie Philip | Peptidic TGF-beta antagonists |
| JP6952747B2 (ja) | 2018-09-18 | 2021-10-20 | ファイザー・インク | がん処置のためのＴＧＦβ阻害剤およびＣＤＫ阻害剤の組合せ |
-
2022
- 2022-09-30 US US18/697,134 patent/US20250034212A1/en active Pending
- 2022-09-30 TW TW111137268A patent/TW202334179A/zh unknown
- 2022-09-30 WO PCT/JP2022/036850 patent/WO2023054712A1/ja not_active Ceased
- 2022-09-30 CN CN202280066544.0A patent/CN118103387A/zh active Pending
- 2022-09-30 CA CA3234324A patent/CA3234324A1/en active Pending
- 2022-09-30 EP EP22876574.9A patent/EP4410816A4/en active Pending
- 2022-09-30 JP JP2023551926A patent/JPWO2023054712A1/ja active Pending
- 2022-09-30 KR KR1020247013802A patent/KR20240082377A/ko active Pending
- 2022-09-30 IL IL311773A patent/IL311773A/en unknown
- 2022-09-30 AU AU2022355276A patent/AU2022355276A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4410816A1 (en) | 2024-08-07 |
| CN118103387A (zh) | 2024-05-28 |
| EP4410816A4 (en) | 2025-11-19 |
| US20250034212A1 (en) | 2025-01-30 |
| WO2023054712A1 (ja) | 2023-04-06 |
| IL311773A (en) | 2024-05-01 |
| KR20240082377A (ko) | 2024-06-10 |
| AU2022355276A1 (en) | 2024-05-16 |
| CA3234324A1 (en) | 2023-04-06 |
| TW202334179A (zh) | 2023-09-01 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250930 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250930 |